Cohort study of HCV reinfection rates after successful DAA treatment in persons who inject drugs, as reported by Clinical Care Options (CCO) at AASLD 2019
Data from AASLD 2019 on viral hepatitis as an underlying cause of HCC among African immigrants in Minnesota as reported by Clinical Care Options.
Data from AASLD 2019 showing that short-course GLE/PIB + EZE prevents HCV transmission in uninfected recipients receiving HCV-infected donor organs.
HCV elimination approaches: Slides from the Clinical Care Options Symposium at the liver meeting 2019, with Oluwaseun Falade-Nwulia, MBBS, MPH
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.